Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma;Place de la chimiothérapie intensive avec autogreffe de cellules souches hématopoïétiques dans le traitement des tumeurs gliales de haut grade chez l'adulte

Bulletin du Cancer

Volumn 88, Issue 9, 2001, Pages 871-876

  Linassier, C ^a   Destrieux, C ^a   Benboubker, L ^a   Alcaraz, L ^a   Bergemer Fouquet, A M ^a   Jan, M ^a   Calais, G ^a   Colombat, P ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Autologous transplantation; Chemotherapy; Glioma

Indexed keywords

CARMUSTINE; MULTIDRUG RESISTANCE PROTEIN; TEMOZOLOMIDE;

BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG TOLERABILITY; GLIOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CARMUSTINE; CISPLATIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; ETOPOSIDE; GLIOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM RECURRENCE, LOCAL; TRANSPLANTATION, AUTOLOGOUS;

EID: 18144447166     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Cancer statistics, 1999
2. Survival after stereotactic biopsy of malignant gliomas
3. Stereotactic imaging, surgical planning and computer-assisted resection of intracranial lesions: Methods and results
4. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome
5. The role of tumor resection in the treatment of glioblastoma multiforme in adults
6. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
7. Radiothérapie des glioblastomes
8. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
9. Chemosensitivity of glioma cells in vitro: A meta analysis
10. Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis
11. Modified procarbazine, CCNU, and vincristine (PCV3) combination chemotherapy in the treatment of malignant brain tumors
12. Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors
13. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
14. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas
15. Procarbazine, lomusrine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy
16. La barrière hémato-encéphalique: Données morphologiques
17. Optimizing drug delivery to brain tumors
18. Heuristic modeling of drug delivery to malignant brain tumors
19. Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors
20. What is the blood-brain barrier? A molecular perspective. Cerebral vascular biology
21. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma
22. Phase III study comparing three cycles of infusional BCNU/cisplatin followed by radiation with radiation and concurrent BCNU for patients with newly diagnosed supratentorial glioblastoma multiforme (ECOG 2394-SWOG 9508)
23. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma
24. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A
25. Treatment of brain gliomas with high dose of CCNU and autologous bone marrow transplantation
26. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas
27. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme
28. Autologous bone-marrow transplantation: Host effects of high-dose BCNU
29. High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma
30. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system
31. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation
32. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma
33. Strategy including surgery, high-dose BCNU followed by ABMT and radiotherapy in supratentorial high-grade astrocytomas: A report of 98 patients
34. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme
35. Post-operative high-dose BCNU followed by autologous bone marrow transplantation and radiotherapy in newly diagnosed high-grade astrocytomas
36. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation
37. High-dose thiotepa with autologous bone matrow transplantation (ABMT) and localized radiotherapy for patients with astrocytoma grade III-IV (glioma): A promising approach
38. Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas
39. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: Report from the Children's Cancer Group